These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25488854)

  • 61. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diabetic nephropathy: Could problems with bardoxolone methyl have been predicted?
    Rossing P
    Nat Rev Nephrol; 2013 Mar; 9(3):128-30. PubMed ID: 23381371
    [No Abstract]   [Full Text] [Related]  

  • 63. Endothelin receptor antagonists and cardiovascular disease.
    Jarvis B; Duff R; Elkinson S
    Drugs R D; 1999 Jul; 2(1):13-6. PubMed ID: 10610274
    [No Abstract]   [Full Text] [Related]  

  • 64. Comment on: have we reached the limits for the treatment of diabetic nephropathy?
    Onuigbo MA
    Expert Opin Investig Drugs; 2014 Jun; 23(6):883-4. PubMed ID: 24797242
    [No Abstract]   [Full Text] [Related]  

  • 65. Molecular, histological, and clinical phenotyping of diabetic nephropathy: valuable complementary information?
    Perco P; Mayer G
    Kidney Int; 2018 Feb; 93(2):308-310. PubMed ID: 29389397
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical aspects of diabetic nephropathy: the prognosis improves.
    Friedman EA
    Contrib Nephrol; 1989; 70():41-55. PubMed ID: 2670439
    [No Abstract]   [Full Text] [Related]  

  • 67. Diabetic nephropathy: Chromatin remodelling in diabetic nephropathy.
    Allison SJ
    Nat Rev Nephrol; 2016 Jul; 12(8):444. PubMed ID: 27425389
    [No Abstract]   [Full Text] [Related]  

  • 68. CURRENT CONCEPTS OF DIABETIC NEPHROPATHY.
    WESTERVELT FB
    Va Med Mon (1918); 1965 Jul; 92():304-7. PubMed ID: 14302306
    [No Abstract]   [Full Text] [Related]  

  • 69. Diabetic nephropathy.
    Semin Nephrol; 1990 May; 10(3):183-293. PubMed ID: 2349400
    [No Abstract]   [Full Text] [Related]  

  • 70. [Genetics of diabetic nephropathy].
    Liu L
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(17):1315-7. PubMed ID: 27180745
    [No Abstract]   [Full Text] [Related]  

  • 71. [Abstracts of the ASN, EASD and ISH 2006 Congresses on Diabetic Nephropathy].
    Nephrol Ther; 2007 Apr; 3 Spec.No. 1():1-11. PubMed ID: 17612029
    [No Abstract]   [Full Text] [Related]  

  • 72. A novel mouse model of advanced diabetic kidney disease.
    Thibodeau JF; Holterman CE; Burger D; Read NC; Reudelhuber TL; Kennedy CR
    PLoS One; 2014; 9(12):e113459. PubMed ID: 25514595
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Low TGFβ1 expression prevents and high expression exacerbates diabetic nephropathy in mice.
    Hathaway CK; Gasim AM; Grant R; Chang AS; Kim HS; Madden VJ; Bagnell CR; Jennette JC; Smithies O; Kakoki M
    Proc Natl Acad Sci U S A; 2015 May; 112(18):5815-20. PubMed ID: 25902541
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bardoxolone methyl prevents fat deposition and inflammation in the visceral fat of mice fed a high-fat diet.
    Dinh CH; Szabo A; Camer D; Yu Y; Wang H; Huang XF
    Chem Biol Interact; 2015 Mar; 229():1-8. PubMed ID: 25637688
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A clinicopathological study of renal biopsies from 288 elderly patients: analysis based on 4,185 cases.
    Yang F; Li B; Cui W; He C; Liu S; Guo Q; Wu M; Miao L; Luo P
    Int Urol Nephrol; 2015 Feb; 47(2):327-33. PubMed ID: 25539617
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A new classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy.
    Haneda M; Utsunomiya K; Koya D; Babazono T; Moriya T; Makino H; Kimura K; Suzuki Y; Wada T; Ogawa S; Inaba M; Kanno Y; Shigematsu T; Masakane I; Tsuchiya K; Honda K; Ichikawa K; Shide K
    Clin Exp Nephrol; 2015 Feb; 19(1):1-5. PubMed ID: 25527479
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Randomized trial of an intensified, multifactorial intervention in patients with advanced-stage diabetic kidney disease: Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan).
    Shikata K; Haneda M; Ninomiya T; Koya D; Suzuki Y; Suzuki D; Ishida H; Akai H; Tomino Y; Uzu T; Nishimura M; Maeda S; Ogawa D; Miyamoto S; Makino H;
    J Diabetes Investig; 2021 Feb; 12(2):207-216. PubMed ID: 32597548
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Atrasentan increased the expression of klotho by mediating miR-199b-5p and prevented renal tubular injury in diabetic nephropathy.
    Kang WL; Xu GS
    Sci Rep; 2016 Jan; 6():19979. PubMed ID: 26813039
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Diabetic nephropathy in 2014: improved cardiorenal prognosis in diabetic nephropathy.
    Parving HH; Rossing P
    Nat Rev Nephrol; 2015 Feb; 11(2):68-70. PubMed ID: 25488854
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Atrasentan Reduces Albuminuria by Restoring the Glomerular Endothelial Glycocalyx Barrier in Diabetic Nephropathy.
    Boels MG; Avramut MC; Koudijs A; Dane MJ; Lee DH; van der Vlag J; Koster AJ; van Zonneveld AJ; van Faassen E; Gröne HJ; van den Berg BM; Rabelink TJ
    Diabetes; 2016 Aug; 65(8):2429-39. PubMed ID: 27207530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.